Ensign Peak Advisors »

Tg Therapeutics shares owned by Ensign Peak Advisors

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Ensign Peak Advisors from 13F filings

Historical chart of Ensign Peak Advisors investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Ensign Peak Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.1M 71k 15.21
2023-09-30 $653k 78k 8.36
2023-06-30 $1.3M 51k 24.84
2023-03-31 $768k 51k 15.04
2022-09-30 $388k 66k 5.92
2022-06-30 $491k 115k 4.25
2022-03-31 $300k 32k 9.51
2021-12-31 $599k 32k 18.99
2021-06-30 $1.7M 44k 38.78
2021-03-31 $2.1M 44k 48.19
2020-12-31 $3.6M 69k 52.01
2020-09-30 $1.8M 68k 26.76